Retraction: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients (Critical Care Medicine (1996) 24 (385-391) DOI: 10.1097/00003246-199603000-00005);Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients

Critical Care Medicine

Volumn 24, Issue 3, 1996, Pages 385-391

  Boldt, Joachim ^a   Müller, Matthias ^a   Heesen, Matthias ^a   Neumann, Karla ^a   Hempelmann, Gunter G ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

adhesion molecules; albumin; critical illness; endothelium; hydroxyethyl starch; inflammatory response; intercellular adhesion molecule 1; pentoxifylline; sepsis

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PENTOXIFYLLINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; HUMAN; INFLAMMATION; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0029984707     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000005910     Document Type: Erratum

References (39)

1. Ley K: Leukocyte adhesion to vascular endothelium. J Reconstr Microsurg 1992; 8:495-503
2. Mariscalco MM: Leukocytes and the inflammatory response. Crit Care Med 1993; 21:S347-S348
3. Williams TJ, Hellewell PG: Endothelial cell biology. Am Rev Respir Dis 1992; 146:S45-S50
4. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3-6
5. Springer TA: Adhesion receptors of the immune system. Nature 1990; 346:425-434
6. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990; 50:537-544
7. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 1993; 14:506-512
8. Ballantyne CE, Mainolfi JB, Young NT: Prognostic value of increased levels of circulating intercellular adhesion molecules-1 after heart transplantation. Abstr. Clin Res 1992; 39:285a
9. Seth R, Raymond FD, Makgoba MW: Circulating ICAM-1 isoforms: Diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338:83-84
10. Jochum M, Inthorn D, Waydhas CH, et al: Diagnostic relevance of PMN elastase and soluble adhesion molecules in acute inflammation. Abstr. Intensive Care Med 1994; 20(Suppl):S102
11. Rothlein R, Mainolfi EA, Czajkowski M, et al: A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793
12. Sessler CN, Windsor A, Watson L, et al: Soluble ICAM-1 receptor levels are increased in human septic shock. Abstr. Chest 1993; 104(Suppl):11S
13. Cowley HC, Heney D, Gearing AJH, et al: Increased circulating adhesion molecule concentrations in patients with septic inflammatory response: A prospective cohort study. Crit Care Med 1994; 22:651-657
14. Vincent J-L: Plugging the leaks? New insights into synthetic colloids. Crit Care Med 1991; 19:316-318
15. Sibbald WJ: Fluid therapy in sepsis. In: Sepsis - Current Perspectives in Pathophysiology and Therapy. Update in Intensive Care and Emergency Medicine. Vol 18. Reinhard K, Eyrich K, Sprung C (Eds). Berlin, Heidelberg, New York, Springer-Verlag, 1994, pp 266-273
16. Walsh CJ, Carey PD, Cook DJ, et al: Anti-CD 18 antibody attenuates neutropenia and alveolar capillary-membrane injury during Gram-negative sepsis. Surgery 1991; 110:205-212
17. Sigurdsson GH, Youssef H: Effects of pentoxifylline on hemodynamics, gas exchange and multiple organ platelet sequestration in experimental endotoxic shock. Acta Anaesthesiol Scand 1993; 37:396-403
18. Coccia MT, Waxman K, Soliman MH, et al: Pentoxifylline improves survival following hemorrhagic shock. Crit Care Med 1989; 17:36-38
19. Soliman HM, O'Neal K, Waxman K: Pentoxifylline improves tissue oxygenation following anesthesia and operation. Crit Care Med 1987; 15:93-94
20. Mandell GL: ARDS, neutrophils, and pentoxifylline, Am Rev Respir Dis 1988; 138:1103-1005
21. Members of the American College of Chest Physicians/Society of Critical Care Medicine Conference Committee: American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
22. Suffredini AF: Current prospects for the treatment of clinical sepsis. Crit Care Med 1994; 22:S12-S18
23. Center DM, Berman JS, Kornfield H, et al: Mechanisms of lymphocyte accumulation in pulmonary disease. Chest 1993; 103(Suppl 3):88S-91S
24. Pelletier RP, Ohye RG, Vanbuskirk A, et al: Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol 1992; 149:2473-2481
25. Lo SK, Lee S, Ramos RA, et al: Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of neutrophil integrin CR3 (CD11a/CD18, Mac-1, alpha and beta-2) on human neutrophils. J Exp Med 1991; 173:1493-1500
26. Chaudry IH, Ayala A: Immune consequences of hypovolemic shock and resuscitation. Curr Opinion Anesth 1993; 6:385-392
27. Yamazaki M, Asakura H, Sato T, et al: Changes in plasma levels of thrombomodulin during haemodialysis. Blood, Coagulation and Fibrinolysis 1992; 3:113-117
28. Sakurabayashi I, Itou S, Ishii H: Studies on granulocyte elastase in plasma. Jpn J Clin Hematol 1985; 33:1113-1118
29. Korthuis RJ, Anderson DC, Granger DN: Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 1994; 9:47-71
30. Lobb R, Chi-Rosso G, Leone DR, et al: Expression and functional characterization of a soluble form of endothelialleucocyte adhesion molecule 1. J Immunol 1991; 147:124-129
31. Kayal S, Guerot E, Rezgui MN, et al: Elevated levels of circulating ICAM-1 and E-selectin in the plasma of patients with severe sepsis syndrome. Abstr. Intensive Care Med 1994; 20(Suppl 1):S26
32. Mayrovitz H, Wiedemann M, Tuma R: Factors influencing leukocyte adherence in microvessels. Thromb Haemost 1977; 38:823-830
33. Boldt J, Zickmann B, Rapin J, et al: Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand 1994; 38: 432-438
34. Schmand JF, Ayala A, Chaudry IH: Influence of hydroxyethylstarch (HES) on inflammatory cytokine release following trauma and hemorrhagic shock. Abstr. Intensive Care Med 1994; 20:325
35. Collis RE, Collins PW, Gutteridge CN, et al: The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994; 20: 37-41
36. Ward A, Clissold SP: Pentoxifylline - A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50-97
37. Hammerschmidt DE, Vercellotti GM: Mechanism of action of pentoxifylline (PTX) in peripheral vascular disease: Inhibition of platelet and granulocyte responsiveness. Clinical Hemorheology 1987; 7:529-533
38. Schönharting M, Musikic P, Müller R: The hemorheological and antithrombotic potential of pentoxifylline (Trental) - A review. Pharmatherapeutica 1988; 5: 159-169
39. Lechner AJ, Rouben LR, Potthoff LH, et al: Effects of pentoxifylline on tumor necrosis production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock 1993; 39:306-315